ID   NALM-36
AC   CVCL_5674
SY   NALM36
DR   JCRB; JCRB1863
DR   Wikidata; Q54907423
RX   PubMed=11734297;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=11734297).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1863
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5676 ! NALM-37
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
RX   PubMed=11734297; DOI=10.1016/S0145-2126(01)00070-4;
RA   Matsuo Y., Drexler H.G., Takeuchi M., Orita K.;
RT   "Establishment of novel B-cell precursor leukemia sister cell lines
RT   NALM-36 and NALM-37: shift of immunoglobulin phenotype to double light
RT   chain positive B-cell.";
RL   Leuk. Res. 26:1-10(2002).
//